This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Effective Endurance Training in Metabolic Syndrome

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00218998
First received: September 20, 2005
Last updated: March 29, 2017
Last verified: March 2017
September 20, 2005
March 29, 2017
January 2004
Not Provided
To reduce risk factors related to metabolic syndrome
To reduce risk factors releatet to metabolic syndrome
Complete list of historical versions of study NCT00218998 on ClinicalTrials.gov Archive Site
Improve endothelial functions in patient with metabolic syndrome
Same as current
Not Provided
Not Provided
 
Effective Endurance Training in Metabolic Syndrome
Effective Endurance Training in Metabolic Syndrome
To see how fast and how much physical training can reduce risk factors related to metabolic syndrome
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Primary Purpose: Prevention
  • Impaired Glucose Tolerance
  • Overweight
  • Hypertension
  • Dyslipidemia
Behavioral: exercise training
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
30
Not Provided
Not Provided

Inclusion Criteria:

  • insulin resistance, impaired glucose tolerance or type 2-diabetes, including two or more of the following factors: Blood pressure ≥ 140/90 mm Hg, Triglycerides Fasting ≥ 1,7 mmol/l, and/or low HDL-cholesterol (≤ 0,9 mmol/l in men, ≤ 1,0 mmol/l in women)
  • Obesity, Waist-hip ratio ≥ 0,9 in men, ≥ 0,85 in women or BMI (body mass index) ≥ 30 kg/m2
  • Microalbuminuria (albumin secretion ≥ 20 mg/l or 20 - 200 g per minute)

Exclusion Criteria:

Sexes Eligible for Study: All
20 Years and older   (Adult, Senior)
Not Provided
Contact information is only displayed when the study is recruiting subjects
Norway
 
 
NCT00218998
Training in metabolic syndrome
No
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Not Provided
Norwegian University of Science and Technology
Norwegian University of Science and Technology
Not Provided
Study Chair: Ulrik E Wisløff, Phd prof NTNU
Norwegian University of Science and Technology
March 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP